Skip to content
Research Article Open access CC BY 4.0

Potential Protective Role of Thymoquinone on Experimentally-induced Alzheimer Rats

Mohammad Fiasal Zaher, Mohamed Abdelfattah Bendary, Gamal Saeed Abd El-Aziz, Ahmed Shaker Ali

Journal of Pharmaceutical Research International · pp. 1–18 · Published 24 Dec 2019

10.9734/jpri/2019/v31i630358

Abstract

Aim: To evaluate the neuroprotective potential of thymoquinine (TQ) on the oxidative stress status of the brain in aluminum chloride (AlCl3)-induced AD in rats. Study Design:  Animal research study. Place and Duration of Study: King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Saudi Arabia, April 2018-June 2019. Methodology: Thirty adult male Sprague Dawley albino rats were randomly divided into 3 groups. Group 1 (Control). Group 2 (AD): supplemented orally with AlCl3 (17 mg/kg/day) for 4 weeks. Group 3 (TQ/AD): supplemented concomitantly with oral TQ (10 mg/kg/day) and AlCl3 (17 mg/kg/day) for 4 weeks. At the end of the experiment, spatial working memory was assessed using the Y-maze spontaneous alternation test. Then, serum levels of malondialdehyde (MDA) and glutathione peroxidase enzyme (GPX) were assessed. Then, the rats were sacrificed, and the brain was isolated, and a light microscopic examination of the hippocampus was performed. Finally, the brain homogenate content of Aβ, tau protein and acetylcholine were biochemically determined. Results: The AD group showed a significant decreased in the spontaneous alteration performance (SAP %) in Y-maze. Also, in the AD group, serum MDA, Aβ and tau protein were significantly increased with a significant decrease of serum GPX and acetylcholine. Examination of H&E-stained sections of the hippocampus of the AD group revealed decreased thickness and disorganization of the pyramidal cell layer of CA1 and CA3 where many pyramidal cells lost their triangular shape and appeared shrunken. The molecular and polymorphic layers showed increased glial cells and congested blood capillaries. The dentate gyrus showed marked disorganization with some cell loss. Co-administration of TQ with AlCl3 in TQ/AD group, improved SAP % and significantly decreased serum MDA, Aβ, tau protein. It also increased serum GPX and acetylcholine levels. Also, TQ partially attenuated the histopathological changes in the hippocampus. Conclusion: TQ could mitigate the oxidative stress markers, neurodegenerative indices and histopathological alteration encountered in AD that all reflected on improving the cognitive behavior. This may implement TQ as an adjuvant medical strategy in ameliorating AD.

Alzheimer's disease AlCl3, thymoquinone oxidative stress Aβ tau protein acetylcholine Y-maze.

References (35)

  1. 1 SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE [DOI]
  2. 2 Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation [DOI]
  3. 3 Oxidative Stress Hypothesis in Alzheimer's Disease [DOI]
  4. 4 Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model [DOI]
  5. 5 Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function [DOI]
  6. 6 Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress [DOI]
  7. 7 Therapeutics of Alzheimer's disease: Past, present and future [DOI]
  8. 8 Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration [DOI]
  9. 9 Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons [DOI]
  10. 10 Relation between Aluminum Concentrations in Drinking Water and Alzheimer's Disease: An 8-year Follow-up Study [DOI]
  11. 11 Human exposure to aluminium [DOI]
  12. 12 Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice [DOI]
  13. 13 Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients.
  14. 14 Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease [DOI]
  15. 15 Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease [DOI]
  16. 16 Prior Pathology in the Basal Forebrain Cholinergic System Predisposes to Inflammation-Induced Working Memory Deficits: Reconciling Inflammatory and Cholinergic Hypotheses of Delirium [DOI]
  17. 17 Alzheimer disease and platelets: how’s that relevant [DOI]
  18. 18 Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity [DOI]
  19. 19 Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice [DOI]
  20. 20 Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory [DOI]
  21. 21 The effects of thymoquinone on hippocampal cytokine level, brain oxidative stress status and memory deficits induced by lipopolysaccharide in rats [DOI]
  22. 22 Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease [DOI]
  23. 23 Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident [DOI]
  24. 24 Remarkable increase in the concentration of 8‐hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease [DOI]
  25. 25 Crystal Structures of the Choline/Acetylcholine Substrate-binding Protein ChoX from Sinorhizobium meliloti in the Liganded and Unliganded-Closed States [DOI]
  26. 26 Cholinergically Mediated Augmentation of Cerebral Perfusion in Alzheimer's Disease and Related Cognitive Disorders: The Cholinergic-Vascular Hypothesis [DOI]
  27. 27 The prevention of the dementia epidemic [DOI]
  28. 28 The impact of neuroimmune changes on development of amyloid pathology; relevance to A lzheimer's disease [DOI]
  29. 29 Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches [DOI]
  30. 30 Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer's disease.
  31. 31 Overexpression of MAP4 inhibits organelle motility and trafficking in vivo [DOI]
  32. 32 Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology [DOI]
  33. 33 Amyloid Beta (Aβ) and Oxidative Stress: Progression of Alzheimer’s Disease [DOI]
  34. 34 Advances in Our Understanding of the Pathophysiology of Alzheimer’s Disease [DOI]
  35. 35 A Functional Analysis of the Projection Domain of the Microtubule Associated Protein Tau Using Force Spectroscopy [DOI]

Cited by 21

Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases

Faheem Hyder Pottoo, Abdallah Mohammad Ibrahim, Ali Alammar · Pharmaceuticals · 2022

Therapeutic Effects of Thymoquinone on Alzheimer’s Disease through Modulating Amyloid-beta Neurotoxicity and Neuro-inflammatory Cytokine Levels

Fawaz Alasmari, Farraj M. Alotaibi, Wedad Saeed Al-Qahtani · CNS & Neurological Disorders - Drug Targets · 2023

Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition

Menna Nafea, Mona Elharoun, Mohammad Mohmoud Abd-Alhaseeb · Naunyn-Schmiedeberg's Archives of Pharmacology · 2022

Showing 5 of 21 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

18

Page views

0

PDF downloads

2

Outbound clicks

21

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.